Stay updated on BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check4 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.0%

- Check11 days agoChange DetectedThe updates are minor UI and metadata changes, including showing the glossary, the Last Update Submitted that Met QC Criteria label, No FEAR Act Data notice, and a Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.3.4 was added, replacing the previous v3.3.3. This is a minor technical update with no changes to study content or results.SummaryDifference0.0%

- Check47 days agoChange DetectedExpanded the Locations section to include a comprehensive list of trial sites across the United States and other regions. Added Revision: v3.3.3.SummaryDifference1%

- Check75 days agoChange DetectedNote added that PubMed-listed publications are auto-filled from PubMed and may not pertain to the study, and the revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedThe government funding operating status notice at the top was removed. The rest of the study details and links remain unchanged.SummaryDifference0.2%

Stay in the know with updates to BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.